Outcome of Immune Tolerance Induction Using an Extended Half-Life Clotting Factor Concentrate — Recombinant Factor VIII Fc (Eloctate™) — a Report from India von Abraham, Aby, Apte, Shashikant, Shamukhaiah, Chandrakala, N., Fouzia, Subramaniam, Kannan, Rahate, Akshata, Singh, Abraham Sunder, Joshi, Aditi, Lakshmi, Kavitha M, Phatale, Rajesh, Shetty, Shrimati, Nair, Sukesh Chandran, George, Biju, Mathews, Vikram, Srivastava, Alok

Volltext